CDT Equity (CDT) Long-Term Debt Issuances (2022 - 2026)
CDT Equity's (CDT) quarterly Long-Term Debt Issuances came in at $487000.0 in Q1 2026, up 222.52% YoY from $151000.0 in Q1 2025, and up 24250.0% on a QoQ basis from $2000.0 in Q3 2025.
CDT Equity (CDT) Long-Term Debt Issuances (2022 - 2026) Analysis & Trends
CDT Equity (CDT) has 5 years of Long-Term Debt Issuances data on file, last reported at $487000.0 in Q1 2026.
- Quarterly Long-Term Debt Issuances rose 222.52% year-over-year to $487000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $494000.0 (down 39.16% YoY) and the FY2025 annual result came in at $158000.0, down 79.64% from the prior year.
- Long-Term Debt Issuances climbed to $487000.0 in Q1 2026, from $2000.0 in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $1.8 million in Q4 2023 to a low of -$849000.0 in Q4 2024.
- A 5-year average of $188416.7 and a median of $4971.5 in 2022 frame the typical range for Long-Term Debt Issuances.
- The widest YoY moves for Long-Term Debt Issuances: up 59700.0% in 2023, down 5724.11% in 2023.
- Tracing CDT's Long-Term Debt Issuances over 5 years: stood at -$3000.0 in 2022, then jumped by 59700.0% to $1.8 million in 2023, then plunged by 147.48% to -$849000.0 in 2024, then jumped by 100.24% to $2000.0 in 2025, then jumped by 24250.0% to $487000.0 in 2026.
- The last three Long-Term Debt Issuances figures came in at $487000.0 (Q1 2026), $2000.0 (Q3 2025), and $5000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CDT Equity | 1.55 Mn | 1.55 Mn | - | 1.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 Mn |
| Jun 30, 2026 | 1.31 Mn |
| Mar 31, 2026 | 487,000.00 |
| Mar 31, 2026 | 487,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 151,000.00 |
| Mar 31, 2025 | 151,000.00 |
| Dec 31, 2024 | -849,000.00 |
| Dec 31, 2024 | -849,000.00 |
| Dec 31, 2023 | 1.79 Mn |
| Dec 31, 2023 | 1.79 Mn |
| Sep 30, 2023 | -278,000.00 |
| Sep 30, 2023 | -278,000.00 |
| Jun 30, 2023 | -10,000.00 |
| Jun 30, 2023 | -10,000.00 |
| Mar 31, 2023 | 786,000.00 |
| Mar 31, 2023 | 786,000.00 |